Safety Rates Drug Report: VENLAFAXINE Foetal exposure during pregnancy adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: VENLAFAXINE Injury: Foetal exposure during pregnancy Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 3 Number of Pages: 1

DRUGNAME	PT	EventCount
VENLAFAXINE	Foetal exposure during pregnancy	23
VENLAFAXINE HCL	Foetal exposure during pregnancy	4
VENLAFAXINE HYDROCHLORIDE.	Foetal exposure during pregnancy	1

|< 1/2 << Previous Page Page 1

Total Records: 3 Number of Pages: 1

Execution Time: 0.24399280548096 seconds (ucode:5289125). Developed by: James D. Barger